Our findings similarly showed a trend toward improvement in asthma-related ED visits or hospitalizations; however, the difference was not of statistical significance, possibly due to the current study’s smaller sample size and shorter follow-up period compared to the mentioned cohort.
← all excerpts
Metformin effects on respiratory and metabolic outcomes in asthma and metabolic syndrome: a double-blind, randomized, placebo-controlled clinical trial.
1
—
—